Cargando…

MicroRNAs in Acute ST Elevation Myocardial Infarction—A New Tool for Diagnosis and Prognosis: Therapeutic Implications

Despite diagnostic and therapeutic advances, coronary artery disease and especially its extreme manifestation, ST elevation myocardial infarction (STEMI), remain the leading causes of morbidity and mortality worldwide. Early and prompt diagnosis is of great importance regarding the prognosis of STEM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scărlătescu, Alina Ioana, Micheu, Miruna Mihaela, Popa-Fotea, Nicoleta-Monica, Dorobanțu, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124280/ https://www.ncbi.nlm.nih.gov/pubmed/33946541 http://dx.doi.org/10.3390/ijms22094799

Ejemplares similares

IL-6, IL-1RA and Resistin as Predictors of Left Ventricular Remodelling and Major Adverse Cardiac Events in Patients with Acute ST Elevation Myocardial Infarction
por: Scărlătescu, Alina Ioana, et al.
Publicado: (2022)

Inflammatory markers in acute myocardial infarction and the correlation with the severity of coronary heart disease
por: Oprescu, Nicoleta, et al.
Publicado: (2021)

Exploring the Continuum of Hypertrophic Cardiomyopathy—From DNA to Clinical Expression
por: Popa-Fotea, Nicoleta Monica, et al.
Publicado: (2019)

Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease
por: Dorobantu, Maria, et al.
Publicado: (2017)

The Role of Left-Atrial Mechanics Assessed by Two-Dimensional Speckle-Tracking Echocardiography to Differentiate Hypertrophic Cardiomyopathy from Hypertensive Left-Ventricular Hypertrophy
por: Popa-Fotea, Nicoleta-Monica, et al.
Publicado: (2021)

The Winding Road of Cardiac Regeneration—Stem Cell Omics in the Spotlight
por: Micheu, Miruna Mihaela, et al.
Publicado: (2018)

The Multifaced Perspectives of Genetic Testing in Pediatric Cardiomyopathies and Channelopathies
por: Popa-Fotea, Nicoleta-Monica, et al.
Publicado: (2020)

miR-146a-5p, miR-223-3p and miR-142-3p as Potential Predictors of Major Adverse Cardiac Events in Young Patients with Acute ST Elevation Myocardial Infarction—Added Value over Left Ventricular Myocardial Work Indices
por: Scărlătescu, Alina Ioana, et al.
Publicado: (2022)

Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction
por: Micheu, Miruna Mihaela, et al.
Publicado: (2017)

Molecular and cellular mechanisms of inflammation in atherosclerosis
por: Popa-Fotea, Nicoleta-Monica, et al.
Publicado: (2023)

Mitochondrial DNA Together with miR-142-3p in Plasma Can Predict Unfavorable Outcomes in Patients after Acute Myocardial Infarction
por: Barbalata, Teodora, et al.
Publicado: (2022)

Acute inferior myocardial infarction in a young man with testicular seminoma: A case report
por: Scafa-Udriste, Alexandru, et al.
Publicado: (2021)

Takotsubo Cardiomyopathy and β-Blocker Poisoning: A Case Report
por: Popa-Fotea, Nicoleta-Monica, et al.
Publicado: (2022)

Yield of Rare Variants Detected by Targeted Next-Generation Sequencing in a Cohort of Romanian Index Patients with Hypertrophic Cardiomyopathy
por: Micheu, Miruna Mihaela, et al.
Publicado: (2020)

Circulating microRNAs in patients with ST-elevation myocardial infarction
por: Eryılmaz, Ufuk, et al.
Publicado: (2016)

Potential benefits and harms of various arterial hypertension guidelines
por: Dorobantu, Maria, et al.
Publicado: (2020)

The Attitude of Patients from a Romanian Tertiary Cardiology Center Regarding Participation in Biomarker-Based Clinical Trials
por: Rusu, Iulia, et al.
Publicado: (2021)

Current Knowledge of MicroRNAs (miRNAs) in Acute Coronary Syndrome (ACS): ST-Elevation Myocardial Infarction (STEMI)
por: Tanase, Daniela Maria, et al.
Publicado: (2021)

Molecular Research in Cardiovascular Disease
por: Dorobantu, Maria, et al.
Publicado: (2021)

The Continuum of Invasive Techniques for the Assessment of Intermediate Coronary Lesions
por: Popa-Fotea, Nicoleta-Monica, et al.
Publicado: (2022)

The Profile and All-Cause In-Hospital Mortality Dynamics of St-Segment Elevation Myocardial Infarction Patients during the Two Years of the COVID-19 Pandemic
por: Popa-Fotea, Nicoleta-Monica, et al.
Publicado: (2023)

Diagnostic Performance of Serum MicroRNAs for ST-Segment Elevation Myocardial Infarction in the Emergency Department
por: Amezcua-Guerra, Brianda, et al.
Publicado: (2023)

The Attitude of Patients from a Romanian Tertiary Cardiology Center as Regards Participation in Biomarker-Based Clinical Trials – Survey Methodology
por: Mihaela Micheu, Miruna, et al.
Publicado: (2018)

Prognosis Between ST-Elevation and Non-ST-elevation Myocardial Infarction in Older Adult Patients
por: Chang, Shih-Sheng, et al.
Publicado: (2022)

Mean Platelet Volume Variability in young patients with Non-ST elevation Acute Myocardial Infarction
por: Andronescu, AM, et al.
Publicado: (2014)

Acute myocardial injury in patients with COVID-19: Possible mechanisms and clinical implications
por: Rusu, Iulia, et al.
Publicado: (2022)

Comparison of Short- and Long-Term Prognosis between ST-Elevation and Non-ST-Elevation Myocardial Infarction
por: Bouisset, Frédéric, et al.
Publicado: (2021)

aVR ST‐segment changes and prognosis of ST‐segment elevation myocardial infarction
por: Sedighi, Sogol, et al.
Publicado: (2021)

The Prognostic Value of Creatine Kinase-MB Dynamics after Primary Angioplasty in ST-Elevation Myocardial Infarctions
por: Popa, Delia Melania, et al.
Publicado: (2023)

MicroRNA-146a Serves as a Biomarker for Adverse Prognosis of ST-Segment Elevation Myocardial Infarction
por: Xiao, Shengjue, et al.
Publicado: (2021)

Moving forward on the pathway of cell-based therapies in ischemic heart disease and heart failure – time for new recommendations?
por: Micheu, Miruna Mihaela
Publicado: (2019)

Tombstoning ST-Elevation Myocardial Infarction
por: Balci, Bahattin
Publicado: (2009)

ST Elevation Myocardial Infarction in the elderly
por: Franken, Marcelo, et al.
Publicado: (2012)

Mistaken ST-Elevation Myocardial Infarction
por: Wolk, Brian J.
Publicado: (2015)

Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease
por: Franczyk-Skóra, Beata, et al.
Publicado: (2013)

Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)
por: Chorell, Elin, et al.
Publicado: (2020)

The clinical features and prognosis of type 4C myocardial infarction in patients with non-ST-segment elevation myocardial infarction
por: Wang, Jixiang, et al.
Publicado: (2021)

Plasma Exosome miRNAs Profile in Patients With ST-Segment Elevation Myocardial Infarction
por: Guan, Ruicong, et al.
Publicado: (2022)

Thyrotoxicosis Mimicking ST Elevation Myocardial Infarction
por: Rymer De Marchena, Ingrid, et al.
Publicado: (2017)

An embolic ST-segment elevation myocardial infarction
por: Feng, Lv, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l5agge2tcn10lna2tdk43ev5rr